摘要
目的对急性胰腺炎临床治疗中使用奥曲肽与乌司他丁联合治疗的效果进行观察性分析。方法选取该院于2013年1月—2014年1月就诊的122例急性胰腺炎患者作为本组研究对象,以抽签的形式将其分为参照组(61例)患者接受奥曲肽治疗,实验组(61例)患者则进行奥曲肽与乌司他丁联合治疗,比较两组患者的临床效果。结果经治疗后,实验组的总有效为96.72%,对照组总有效率仅有80.33%,可见实验组的临床效果优于参照组,差异存在统计意义(P<0.05)。结论急性胰腺炎的临床治疗中,运用奥曲肽与乌司他丁联合治疗的效果显著,应广泛应用。
Objective To use in clinical treatment of acute pancreatitis Mr Qu peptide and the effect of ulinastatin combined observational analysis. Methods In our hospital 122 cases of acute pancreatitis patients in 2013 January to 2014 January as the research object, in the form of the draw its divided into control group（61 cases） patients received the peptide treatment, the treatment group（61 cases） patients in the combination treatment with octreotide and ulinastatin, to compare the clinical effect of two groups of pa-tients. Results After treatment, the experimental group, the total effective was 96.72%, only 80.33% of the control group total effective rate, the clinical effect of the experimental group is better than that of control group, the difference is statistically significant（P〈0.05）. Conclusion In clinical treatment of acute pancreatitis, using Mr Qu peptide and ulinastatin combined treatment effect is remarkable, should be widely used.
出处
《中国卫生产业》
2014年第34期12-13,16,共3页
China Health Industry
关键词
奥曲肽
乌司他丁
治疗
急性胰腺炎
The octreotide
Ulinastatin
Treatment
Acute pancreatitis
